tiprankstipranks
Revvity (MX:RVTY)
:RVTY
Mexico Market
RVTY
Revvity
RESEARCH TOOLSreports

Revvity (RVTY) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

RVTY Analyst Ratings

Moderate Buy
11Ratings
Moderate Buy
4 Buy
7 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Revvity
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

RVTY Stock 12 Month Forecast

Average Price Target

$2,141.50
▲(12.12% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Revvity in the last 3 months. The average price target is $2,141.50 with a high forecast of $2,802.12 and a low forecast of $1,868.08. The average price target represents a 12.12% change from the last price of $1,910.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1643":"$1,643","1933":"$1,933","2223":"$2,223","2513":"$2,513","2803":"$2,803"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2802.11942175,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$2.80K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2141.4985398950002,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$2.14K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1868.0796145000002,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$1.87K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1643,1933,2223,2513,2803],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1910,1978.6245709038462,2047.2491418076922,2115.8737127115382,2184.4982836153845,2253.1228545192307,2321.747425423077,2390.371996326923,2458.9965672307694,2527.6211381346156,2596.2457090384614,2664.8702799423077,2733.494850846154,{"y":2802.11942175,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1910,1927.8075799919231,1945.6151599838463,1963.4227399757692,1981.2303199676924,1999.0378999596155,2016.8454799515387,2034.6530599434616,2052.4606399353847,2070.2682199273077,2088.075799919231,2105.883379911154,2123.6909599030773,{"y":2141.4985398950002,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1910,1906.7753549615384,1903.550709923077,1900.3260648846153,1897.101419846154,1893.8767748076923,1890.652129769231,1887.4274847307693,1884.2028396923079,1880.9781946538462,1877.7535496153848,1874.5289045769232,1871.3042595384618,{"y":1868.0796145000002,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1661.021,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1661.021,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1746.7,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1746.7,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1746.7,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1746.7,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1644.85,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1644.85,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1644.85,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1644.85,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1644.85,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1910,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1910,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$2,802Average Price Target$2,141Lowest Price Target$1,868
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wolfe Research Analyst forecast on MX:RVTY
Doug Schenkel
Wolfe Research
Wolfe Research
$2,037.91→$2,377.56
Hold
24.48%
Upside
Downgraded
09/09/26
Revvity (RVTY) Receives a New Rating from UBS
Bernstein Analyst forecast on MX:RVTY
Eve Burstein
Bernstein
Bernstein
$1,952.99→$2,037.91
Hold
6.70%
Upside
Reiterated
09/09/26
Bernstein Keeps Their Hold Rating on Revvity (RVTY)
KeyBanc Analyst forecast on MX:RVTY
Paul Knight
KeyBanc
KeyBanc
$2,122.82→$2,802.12
Buy
46.71%
Upside
Reiterated
09/04/26
KeyBanc Sticks to Their Buy Rating for Revvity (RVTY)
RBC Capital Analyst forecast on MX:RVTY
Dan Leonard
RBC Capital
RBC Capital
$2,292.64
Hold
20.03%
Upside
Initiated
09/01/26
Revvity initiated with a Sector Perform at RBC CapitalRevvity initiated with a Sector Perform at RBC Capital
TD Cowen Analyst forecast on MX:RVTY
Daniel Brennan
TD Cowen
TD Cowen
$2,207.73
Buy
15.59%
Upside
Assigned
08/07/26
Revvity: Solid Q2, Raised Guidance and AI‑Driven Backlog Support Buy Rating and $130 Price Target
J.P. Morgan Analyst forecast on MX:RVTY
Casey Woodring
J.P. Morgan
J.P. Morgan
$1,868.08
Hold
-2.19%
Downside
Reiterated
08/06/26
J.P. Morgan Reaffirms Their Hold Rating on Revvity (RVTY)
Wells Fargo Analyst forecast on MX:RVTY
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
$1,868.08
Hold
-2.19%
Downside
Reiterated
08/05/26
Wells Fargo Sticks to Its Hold Rating for Revvity (RVTY)
Stifel Nicolaus Analyst forecast on MX:RVTY
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$1,698.25→$1,868.08
Hold
-2.19%
Downside
Assigned
08/05/26
Revvity price target raised to $110 from $100 at StifelRevvity price target raised to $110 from $100 at Stifel
Evercore ISI Analyst forecast on MX:RVTY
Vijay Kumar
Evercore ISI
Evercore ISI
$2,122.82→$2,139.8
Buy
12.03%
Upside
Reiterated
08/05/26
Revvity price target raised to $126 from $125 at Evercore ISIRevvity price target raised to $126 from $125 at Evercore ISI
Barclays Analyst forecast on MX:RVTY
Luke Sergott
Barclays
Barclays
$1,783.17→$1,952.99
Hold
2.25%
Upside
Reiterated
08/04/26
Leerink Partners Analyst forecast on MX:RVTY
Puneet Souda
Leerink Partners
Leerink Partners
―
Buy
―
Reiterated
07/17/26
Revvity (RVTY) Receives a Buy from Leerink Partners
Wolfe Research Analyst forecast on MX:RVTY
Michael Polark
Wolfe Research
Wolfe Research
―
Hold
―
Initiated
06/01/26
Revvity assumed with a Peer Perform at Wolfe ResearchRevvity assumed with a Peer Perform at Wolfe Research
Bank of America Securities Analyst forecast on MX:RVTY
Michael Ryskin
Bank of America Securities
Bank of America Securities
―
Hold
―
Reiterated
05/14/26
Analysts Conflicted on These Healthcare Names: Cullinan Management (NASDAQ: CGEM), Humacyte (NASDAQ: HUMA) and Revvity (NYSE: RVTY)
Guggenheim Analyst forecast on MX:RVTY
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
―
Hold
―
Reiterated
05/11/26
Revvity (RVTY) Receives a Hold from Guggenheim
Goldman Sachs Analyst forecast on MX:RVTY
Evie Koslosky
Goldman Sachs
Goldman Sachs
$1,613.34→$1,698.25
Hold
-11.09%
Downside
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Revvity (NYSE: RVTY), Vir Biotechnology (NASDAQ: VIR) and Johnson & Johnson (NYSE: JNJ)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wolfe Research Analyst forecast on MX:RVTY
Doug Schenkel
Wolfe Research
Wolfe Research
$2,037.91→$2,377.56
Hold
24.48%
Upside
Downgraded
09/09/26
Revvity (RVTY) Receives a New Rating from UBS
Bernstein Analyst forecast on MX:RVTY
Eve Burstein
Bernstein
Bernstein
$1,952.99→$2,037.91
Hold
6.70%
Upside
Reiterated
09/09/26
Bernstein Keeps Their Hold Rating on Revvity (RVTY)
KeyBanc Analyst forecast on MX:RVTY
Paul Knight
KeyBanc
KeyBanc
$2,122.82→$2,802.12
Buy
46.71%
Upside
Reiterated
09/04/26
KeyBanc Sticks to Their Buy Rating for Revvity (RVTY)
RBC Capital Analyst forecast on MX:RVTY
Dan Leonard
RBC Capital
RBC Capital
$2,292.64
Hold
20.03%
Upside
Initiated
09/01/26
Revvity initiated with a Sector Perform at RBC CapitalRevvity initiated with a Sector Perform at RBC Capital
TD Cowen Analyst forecast on MX:RVTY
Daniel Brennan
TD Cowen
TD Cowen
$2,207.73
Buy
15.59%
Upside
Assigned
08/07/26
Revvity: Solid Q2, Raised Guidance and AI‑Driven Backlog Support Buy Rating and $130 Price Target
J.P. Morgan Analyst forecast on MX:RVTY
Casey Woodring
J.P. Morgan
J.P. Morgan
$1,868.08
Hold
-2.19%
Downside
Reiterated
08/06/26
J.P. Morgan Reaffirms Their Hold Rating on Revvity (RVTY)
Wells Fargo Analyst forecast on MX:RVTY
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
$1,868.08
Hold
-2.19%
Downside
Reiterated
08/05/26
Wells Fargo Sticks to Its Hold Rating for Revvity (RVTY)
Stifel Nicolaus Analyst forecast on MX:RVTY
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$1,698.25→$1,868.08
Hold
-2.19%
Downside
Assigned
08/05/26
Revvity price target raised to $110 from $100 at StifelRevvity price target raised to $110 from $100 at Stifel
Evercore ISI Analyst forecast on MX:RVTY
Vijay Kumar
Evercore ISI
Evercore ISI
$2,122.82→$2,139.8
Buy
12.03%
Upside
Reiterated
08/05/26
Revvity price target raised to $126 from $125 at Evercore ISIRevvity price target raised to $126 from $125 at Evercore ISI
Barclays Analyst forecast on MX:RVTY
Luke Sergott
Barclays
Barclays
$1,783.17→$1,952.99
Hold
2.25%
Upside
Reiterated
08/04/26
Leerink Partners Analyst forecast on MX:RVTY
Puneet Souda
Leerink Partners
Leerink Partners
―
Buy
―
Reiterated
07/17/26
Revvity (RVTY) Receives a Buy from Leerink Partners
Wolfe Research Analyst forecast on MX:RVTY
Michael Polark
Wolfe Research
Wolfe Research
―
Hold
―
Initiated
06/01/26
Revvity assumed with a Peer Perform at Wolfe ResearchRevvity assumed with a Peer Perform at Wolfe Research
Bank of America Securities Analyst forecast on MX:RVTY
Michael Ryskin
Bank of America Securities
Bank of America Securities
―
Hold
―
Reiterated
05/14/26
Analysts Conflicted on These Healthcare Names: Cullinan Management (NASDAQ: CGEM), Humacyte (NASDAQ: HUMA) and Revvity (NYSE: RVTY)
Guggenheim Analyst forecast on MX:RVTY
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
―
Hold
―
Reiterated
05/11/26
Revvity (RVTY) Receives a Hold from Guggenheim
Goldman Sachs Analyst forecast on MX:RVTY
Evie Koslosky
Goldman Sachs
Goldman Sachs
$1,613.34→$1,698.25
Hold
-11.09%
Downside
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Revvity (NYSE: RVTY), Vir Biotechnology (NASDAQ: VIR) and Johnson & Johnson (NYSE: JNJ)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
JAZZJazz Pharmaceuticals
ONCBeOne Medicines
VKTXViking Therapeutics
HROWHarrow Health
KURAKura Oncology
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Revvity

3 Months
Catherine Ramsey SchulteRobert W. Baird
Success Rate
24/37 ratings generated profit
65%
Average Return
+3.05%
Copying Catherine Ramsey Schulte's trades and holding each position for 3 Months would result in 64.86% of your transactions generating a profit, with an average return of +3.05% per trade.
1 Year
Daniel BrennanTD Cowen
Success Rate
11/16 ratings generated profit
69%
Average Return
+10.27%
Copying Daniel Brennan's trades and holding each position for 1 Year would result in 68.75% of your transactions generating a profit, with an average return of +10.27% per trade.
2 Years
Puneet SoudaLeerink Partners
Success Rate
10/11 ratings generated profit
91%
Average Return
+16.85%
Copying Puneet Souda's trades and holding each position for 2 Years would result in 90.91% of your transactions generating a profit, with an average return of +16.85% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RVTY Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
0
0
0
0
0
Buy
3
4
6
6
6
Hold
11
11
10
8
8
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
15
16
14
14
In the current month, RVTY has received 6 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. RVTY average Analyst price target in the past 3 months is 2,141.50.
Each month's total comprises the sum of three months' worth of ratings.

RVTY Financial Forecast

RVTY Earnings Forecast

Next quarter’s earnings estimate for RVTY is $21.99 with a range of $21.74 to $22.93. The previous quarter’s EPS was $23.95. RVTY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year RVTY has Performed in-line its overall industry.
Next quarter’s earnings estimate for RVTY is $21.99 with a range of $21.74 to $22.93. The previous quarter’s EPS was $23.95. RVTY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year RVTY has Performed in-line its overall industry.

RVTY Sales Forecast

Next quarter’s sales forecast for RVTY is $11.79B with a range of $11.73B to $11.90B. The previous quarter’s sales results were $12.39B. RVTY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year RVTY has Performed in-line its overall industry.
Next quarter’s sales forecast for RVTY is $11.79B with a range of $11.73B to $11.90B. The previous quarter’s sales results were $12.39B. RVTY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year RVTY has Performed in-line its overall industry.

RVTY Stock Forecast FAQ

What is MX:RVTY’s average 12-month price target, according to analysts?
Based on analyst ratings, Revvity’s 12-month average price target is 2,141.50.
    What is MX:RVTY’s upside potential, based on the analysts’ average price target?
    Revvity has 12.12% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Revvity a Buy, Sell or Hold?
          Revvity has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 7 hold ratings and 0 sell ratings.
            What is Revvity’s share price target?
            The average share price target for Revvity is 2,141.50. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $2,802.12 ,and the lowest forecast is $1,868.08. The average share price target represents 12.12% Increase from the current price of $1,910.
              What do analysts say about Revvity?
              Revvity’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of Revvity?
                To buy shares of MX:RVTY, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.